GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemostemix Inc (OTCPK:HMTXF) » Definitions » Price-to-Funds-From-Operations

HMTXF (Hemostemix) Price-to-Funds-From-Operations : (As of Apr. 23, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hemostemix Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Hemostemix Business Description

Industry
Traded in Other Exchanges
Address
707 - 7th Avenue SouthWest, Suite 1150, Calgary, AB, CAN, T2P 3H6
Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.